Business
Perimeter Medical Imaging AI Announces Transition of Key Leadership Roles Appointing Jeremy Sobotta as Chief Executive Officer and Tom Boon as Chief Operating Officer
TORONTO, ON / ACCESSWIRE / October 20, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"Perimeter Medical Imaging AI Announces Transition of Key Leadership Roles Appointing Jeremy Sobotta as Chief Executive Officer and Tom Boon as Chief Operating OfficerTORONTO, ON / ACCESSWIRE / October 20, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC) (\"Perimeter\" or the \"Company\"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, is pleased to announce a transition to new roles for two of the Company's senior leaders with the appointment of Jeremy Sobotta as Chief Executive Officer and Tom Boon as Chief Operating Officer, both effective immediately. Rounding out Perimeter's senior leadership team are Liz Munro, President of Canadian Operations and Steve Sapot, Chief Commercial Officer.Dr. Anthony Holler, Chair of Perimeter's Board of Directors, commented, \"Today's announcement reflects a natural transition that recognizes the great leadership team we already have in place at Perimeter and our maturation as a public company. Moving forward, Jeremy will continue to represent Perimeter in the capital markets and focus on leading the Company as it grows and executes on its strategic plans, while we continue to draw upon Tom's extensive operational expertise to build the appropriate infrastructure for a commercial organization. Backed by a strong Board and world-leading experts on our scientific advisory committee, we believe we have the right team in place to achieve our clinical development and commercial goals.\"Mr. Sobotta stated, \"I am pleased to take on the CEO role and privileged to lead Perimeter's dedicated team at such an exciting time when we are commercializing our existing specimen imaging technology and completing pivotal clinical studies for our artificial intelligence. Since joining the Company, I have seen its tremendous potential for growth and long-term success with our unique technology. We have built a team with an immense amount of medtech knowledge, a commitment to bringing our innovative technology to market, and a passion to help our customers improve the lives of patients with breast cancer.\"Having previously served as Chief Financial Officer of Perimeter, Mr. Sobotta joined the Company with a diverse background in the medical devices industry supporting many diffe...